Title for MeetingAbstracts
Alphabetical listing of titles
-
HIV--does symptom free mean problem free?
-
HIV-1 (HIV) isolates resistant to both AZT and ddI developing in patients receiving combination therapy contain unique pol gene mutations.
-
HIV-1 (Rf) variants with a single amino acid substitution at the protease (Val82 to Ala) have a reduced sensitivity to C-2 symmetrical inhibitors of HIV-1 protease.
-
HIV-1 2 LTR circle dynamics in vivo.
-
HIV-1 5'-LTRs from 42 patients representing all stages of infection, display a wide range of polymorphism in sequence, transcription potential and binding of factors but no clinical correlation.
-
HIV-1 acquires resistance to AZT and Delavirdine in vitro by multiple RT substitutions.
-
HIV-1 acquires resistance to multiple classes of antiviral drugs through recombination.
-
HIV-1 acts as a superantigen: TCR V beta expression regulates HIV replication.
-
HIV-1 Acute Infection Env Glycomutants Designed from 3D-Model: Effects on Processing, Antigenicity and Neutralization Sensitivity.
-
HIV-1 adaptation during infection of HL-60 cells.
-
HIV-1 among applicants for life, health, and disability insurance, 1991-1992.
-
HIV-1 and -chemokine inhibitory activities of anti-CCR5 antibodies map to distinct CCR5 epitopes.
-
HIV-1 and cancer in South Africa.
-
HIV-1 and hepatitis B and C multiple infection are common in Cameroon.
-
HIV-1 and hepatitis C seroprevalence among hilltribe drug users, Chiang Rai Province, Thailand.
-
HIV-1 and hepatitis C virus infections among recent injecting drug users.
-
HIV-1 and HIV-1 inhibitory activity in breast milk.
-
HIV-1 and HIV-2 chimeric lentiviral vectors for gene therapy and gene function identification.
-
HIV-1 and HIV-2 envelope glycoproteins are lectins.
-
HIV-1 and HIV-2 infection in pregnant women in The Gambia: risk factors.
-
HIV-1 and HIV-2 infection prevalence in the mortuary-Abidjan.
-
HIV-1 and HIV-2 infections in mothers and children in Abidjan, Cote d'Ivoire.
-
HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells.
-
HIV-1 and HIV-2 serological studies in individuals with risk behavior.
-
HIV-1 and HIV-2 serological study carried out on blood donors from Guinea Bissau.
-
HIV-1 and HIV-2 seroprevalence and risk factors in Maiduguri, Nigeria.
-
HIV-1 and HIV-2 seroprevalence in childbearing women at outcome of pregnancy in the Paris area, France.
-
HIV-1 and HIV-2 seroprevalence in three communities of Ghana, West Africa.
-
HIV-1 and HIV-2 specific IgG subclass reactivity to env and gag peptides.
-
HIV-1 and HIV-2 status in Ghanaian AIDS and ARC patients.